TY  - GEN
AU  - Raw,Andre S
AU  - Furness,M Scott
AU  - Gill,Devinder S
AU  - Adams,Richard C
AU  - Holcombe,Frank O
AU  - Yu,Lawrence X
TI  - Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)
SN  - 0169-409X
PY  - 2004///1026
KW  - Biological Availability
KW  - Carbamazepine
KW  - chemistry
KW  - Cefuroxime
KW  - analogs & derivatives
KW  - Chemistry Techniques, Analytical
KW  - Crystallography
KW  - Decision Trees
KW  - Drug Approval
KW  - methods
KW  - Drug Stability
KW  - Drugs, Generic
KW  - Enalapril
KW  - Humans
KW  - Molecular Conformation
KW  - Phase Transition
KW  - Prazosin
KW  - Quality Control
KW  - Ranitidine
KW  - Solubility
KW  - Sulfonamides
KW  - Technology, Pharmaceutical
KW  - Therapeutic Equivalency
KW  - Torsemide
KW  - United States
KW  - United States Food and Drug Administration
KW  - Warfarin
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.addr.2003.10.011
ER  -